These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2685015)

  • 1. Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.
    Nagano Y; Nagano N; Takahashi S; Suzuki A; Okuwaki Y
    J Clin Microbiol; 1989 Oct; 27(10):2148-51. PubMed ID: 2685015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of type Ia and Ib Streptococcus agalactiae strains with high sialic acid levels by determination of susceptibility to tetracyclines.
    Nagano Y; Nagano N; Takahashi S; Suzuki A; Okuwaki Y
    J Clin Microbiol; 1989 Dec; 27(12):2767-71. PubMed ID: 2687321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.
    Maurer JJ; Mattingly SJ
    J Clin Microbiol; 1988 Apr; 26(4):686-91. PubMed ID: 3284898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A search for new group-B streptococcal serotypes.
    Motlová J; Wagner M; Jelínková J
    J Med Microbiol; 1986 Sep; 22(2):101-5. PubMed ID: 3528496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of neuD transcription levels and capsular sialic acid expression among serotype III group B Streptococcus strains.
    Lartigue MF; Poulard AF; Al Safadi R; Pailhories H; Domelier-Valentin AS; van der Mee-Marquet N; Rosenau A; Quentin R
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3282-3291. PubMed ID: 21852348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
    Platt MW; Correa N; Mold C
    Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).
    Orefici G; Recchia S; Galante L
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):302-5. PubMed ID: 3134236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sialic contents on the chemiluminescent response of human leucocytes to group B streptococci.
    De Paoli P; Mucignat C; Orefici G; Santini G
    Microbiologica; 1985 Oct; 8(4):379-86. PubMed ID: 3906368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.
    Nealon TJ; Mattingly SJ
    Infect Immun; 1983 Mar; 39(3):1243-51. PubMed ID: 6341233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae].
    Martínez MA; Ovalle A; Durán C; Reid I; Urriola G; Garay B; Cifuentes M
    Rev Med Chil; 2004 May; 132(5):549-55. PubMed ID: 15279140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of growth in human serum on an acapsular group B Streptococcus mutant.
    Platt MW; Scaletti J; Correa N
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):245-51. PubMed ID: 7812272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains.
    Domelier AS; van der Mee-Marquet N; Arnault L; Mereghetti L; Lanotte P; Rosenau A; Lartigue MF; Quentin R
    J Antimicrob Chemother; 2008 Dec; 62(6):1227-33. PubMed ID: 18786936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of the serotype distribution, biofilm production and antibiotic susceptibilities of group B streptococci isolated from urinary samples].
    Baba S; Aydın MD
    Mikrobiyol Bul; 2016 Jul; 50(3):353-60. PubMed ID: 27525391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.
    Moyo SR; Maeland JA; Bergh K
    J Med Microbiol; 2002 Jul; 51(7):595-662. PubMed ID: 12132777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.
    Alhhazmi A; Pandey A; Tyrrell GJ
    J Clin Microbiol; 2017 Sep; 55(9):2637-2650. PubMed ID: 28615470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden.
    Berg S; Trollfors B; Lagergård T; Zackrisson G; Claesson BA
    Clin Microbiol Infect; 2000 Jan; 6(1):9-13. PubMed ID: 11168030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
    von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
    Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
    Wessels MR; Haft RF; Heggen LM; Rubens CE
    Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-electronmicroscopic demonstration of capsules on group-B streptococci of new serotypes and type candidates.
    Rýc M; Jelínková J; Motlová J; Wagner M
    J Med Microbiol; 1988 Feb; 25(2):147-9. PubMed ID: 3276898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
    Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
    J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.